ALTERED IPSC-DERIVED NEURONS' SODIUM CHANNEL PROPERTIES IN SUBJECTS WITH MONGE'S DISEASE

被引:13
|
作者
Zhao, H. W. [1 ]
Gu, X. Q. [1 ]
Chailangkarn, T. [1 ,2 ]
Perkins, G. [4 ]
Callacondo, D. [1 ,5 ]
Appenzeller, O. [6 ]
Poulsen, O. [1 ]
Zhou, D. [1 ]
Muotri, A. R. [1 ,2 ,7 ]
Haddad, G. G. [1 ,3 ,7 ]
机构
[1] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA
[5] Univ Peruana Cayetano Heredia, Lab Invest & Desarrollo, Lima 36, Peru
[6] New Mexico Hlth Enhancement & Marathon Clin Res F, Albuquerque, NM 87122 USA
[7] Rady Childrens Hosp, San Diego, CA 92123 USA
基金
美国国家卫生研究院;
关键词
chronic mountain sickness; induced pluripotent stem cells; neurons; Na+ channel; CHRONIC MOUNTAIN-SICKNESS; PLURIPOTENT STEM-CELLS; HIGH-ALTITUDE SICKNESS; TIBETAN CHINESE; MIGRAINE; ADULT; BRAIN; ACETAZOLAMIDE; ASSOCIATIONS; DEPRIVATION;
D O I
10.1016/j.neuroscience.2014.12.039
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Monge's disease, also known as chronic mountain sickness (CMS), is a disease that potentially threatens more than 140 million highlanders during extended time living at high altitudes (over 2500 m). The prevalence of CMS in Andeans is about 15-20%, suggesting that the majority of highlanders (non-CMS) are rather healthy at high altitudes; however, CMS subjects experience severe hypoxemia, erythrocytosis and many neurologic manifestations including migraine, headache, mental fatigue, confusion, and memory loss. The underlying mechanisms of CMS neuropathology are not well understood and no ideal treatment is available to prevent or cure CMS, except for phlebotomy. In the current study, we reprogrammed fibroblast cells from both CMS and non-CMS subjects' skin biopsies into the induced pluripotent stem cells (iPSCs), then differentiated into neurons and compared their neuronal properties. We discovered that CMS neurons were much less excitable (higher rheobase) than non-CMS neurons. This decreased excitability was not caused by differences in passive neuronal properties, but instead by a significantly lowered Na+ channel current density and by a shift of the voltage-conductance curve in the depolarization direction. Our findings provide, for the first time, evidence of a neuronal abnormality in CMS subjects as compared to non-CMS subjects, hoping that such studies can pave the way to a better understanding of the neuropathology in CMS. (C) 2014 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:187 / 199
页数:13
相关论文
共 50 条
  • [41] Assessing the therapeutic potential of Graptopetalum paraguayense on Alzheimer's disease using patient iPSC-derived neurons
    Wu, Pei-Chun
    Fann, Ming-Ji
    Tu Thanh Tran
    Chen, Shu-Cian
    Devina, Tania
    Cheng, Irene Han-Juo
    Lien, Cheng-Chang
    Kao, Lung-Sen
    Wang, Shuu-Jiun
    Fuh, Jong-Ling
    Tzeng, Tsai-Teng
    Huang, Chi-Ying
    Shiao, Young-Ji
    Wong, Yu-Hui
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [42] iPSC-Derived Dopamine Neurons Reveal Differences between Monozygotic Twins Discordant for Parkinson's Disease
    Woodard, Chris M.
    Campos, Brian A.
    Kuo, Sheng-Han
    Nirenberg, Melissa J.
    Nestor, Michael W.
    Zimmer, Matthew
    Mosharov, Eugene V.
    Sulzer, David
    Zhou, Hongyan
    Paull, Daniel
    Clark, Lorraine
    Schadt, Eric E.
    Sardi, Sergio Pablo
    Rubin, Lee
    Eggan, Kevin
    Brock, Mathew
    Lipnick, Scott
    Rao, Mahendra
    Chang, Stephen
    Li, Aiqun
    Noggle, Scott A.
    CELL REPORTS, 2014, 9 (04): : 1173 - 1182
  • [43] Molecular and functional variation in iPSC-derived sensory neurons
    Schwartzentruber, Jeremy
    Foskolou, Stefanie
    Kilpinen, Helena
    Rodrigues, Julia
    Alasoo, Kaur
    Knights, Andrew J.
    Patel, Minal
    Goncalves, Angela
    Ferreira, Rita
    Benn, Caroline Louise
    Wilbrey, Anna
    Bictash, Magda
    Impey, Emma
    Cao, Lishuang
    Lainez, Sergio
    Loucif, Alexandre Julien
    Whiting, Paul John
    Gutteridge, Alex
    Gaffney, Daniel J.
    NATURE GENETICS, 2018, 50 (01) : 54 - +
  • [44] The Early Oscillatory Activity In Human IPSC-Derived Neurons
    Rosa, F.
    Mendez, D.
    Loeffler, H.
    Elsen, G.
    Mueller, S.
    Schwarz, N.
    Uysal, B.
    Reid, C.
    Petrou, S.
    Lerche, H.
    Maljevic, S.
    EPILEPSIA, 2019, 60 : 47 - 48
  • [45] Multiomics Evaluation of Human iPSCs and iPSC-Derived Neurons
    Lee, Gwang Bin
    Mazli, Wan Nur Atiqah binti
    Hao, Ling
    JOURNAL OF PROTEOME RESEARCH, 2024, 23 (08) : 3149 - 3160
  • [46] The Human Brain in a Dish: The Promise of iPSC-Derived Neurons
    Dolmetsch, Ricardo
    Geschwind, Daniel H.
    CELL, 2011, 145 (06) : 831 - 834
  • [47] How is Excitotoxicity Being Modelled in iPSC-Derived Neurons?
    Cheng, Jan L.
    Cook, Anthony L.
    Talbot, Jana
    Perry, Sharn
    NEUROTOXICITY RESEARCH, 2024, 42 (05)
  • [48] Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects
    Workman, Michael J.
    Lim, Ryan G.
    Wu, Jie
    Frank, Aaron
    Ornelas, Loren
    Panther, Lindsay
    Galvez, Erick
    Perez, Daniel
    Meepe, Imara
    Lei, Susan
    Valencia, Viviana
    Gomez, Emilda
    Liu, Chunyan
    Moran, Ruby
    Pinedo, Louis
    Tsitkov, Stanislav
    Ho, Ritchie
    Kaye, Julia A.
    Thompson, Terri
    Rothstein, Jeffrey D.
    Finkbeiner, Steven
    Fraenkel, Ernest
    Sareen, Dhruv
    Thompson, Leslie M.
    Svendsen, Clive N.
    NEURON, 2023, 111 (08) : 1191 - +
  • [49] Human iPSC-derived cardiomyocytes and neurons enable the study of innate and induced disease pathologies
    Hussey, Dominic
    HUMAN GENE THERAPY, 2015, 26 (09) : A28 - A29
  • [50] Applications of iPSC-derived models of Gaucher disease
    Borger, Daniel K.
    Aflaki, Elma
    Sidransky, Ellen
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (19)